Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 4

Increased incidence of malignancy in patients with primary hyperparathyroidism

Pages
2023–2028
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

More comprehensive studies are needed to clarify the relationship between PHPT and cancer.Key words: Primary hyperparathyroidism, cancer, thyroid cancer

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Primary hyperparathyroidism (PHPT) is a disease that is diagnosed more frequently and generally in the asymptomatic period, with widely available biochemical tests.
📊
Key Findings & Data:Materials and methods: A total of 775 PHPT patients were included in the retrospective study.
💡
Conclusion & Impact:More comprehensive studies are needed to clarify the relationship between PHPT and cancer.Key words: Primary hyperparathyroidism, cancer, thyroid cancer
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Primary hyperparathyroidism (PHPT) is a disease that is diagnosed more frequently and generally in the asymptomatic period, with widely available biochemical tests. Evidence suggesting an association between PHPT and malignancy risk is increasing. Clarification of this association will be useful in PHPT for malignancy screening and management of patients with PHPT. In this study, we aimed to investigate the frequency of cancer in PHPT patients. Materials and methods: A total of 775 PHPT patients were included in the retrospective study. Demographic, clinical and laboratory data of the patients were evaluated retrospectively. Results: Malignancy was detected in 128 (16.50%) of 775 PHPT patients (female/male: 625/150). The mean age at diagnosis of PHPT was 57.99 ± 10.86 years, and the mean age at diagnosis of malignancy was 57.46 ± 11.17 years. Of the 128 patients with malignancy, 53 (41.40%) were diagnosed in the same year as PHPT. In terms of malignancy types, 51 (6.50%) of 775 PHPT patients had thyroid cancer. Thyroid cancer was followed by breast cancer (2.30%) and stomach cancer (1%) in order of frequency. Conclusion: We think that PHPT patients should be examined more carefully in terms of cancer risk, especially thyroid cancer. More comprehensive studies are needed to clarify the relationship between PHPT and cancer.Key words: Primary hyperparathyroidism, cancer, thyroid cancer

🔖

Cite This Article

KULAKSIZOĞLU, M., CAN, M., ÇORDAN, İ., KOCABAŞ, M., KARAKÖSE, M., BURGUCU, H. Ç., KARAKURT, F. (2022). Increased incidence of malignancy in patients with primary hyperparathyroidism. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 4, 2023–2028. https://ajindex.com/articles/609390

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Silverberg SJ, Bilezikian JP. Asymptomatic primary hyperparathyroidism: a medical perspective. Surgical Clinics of North America 2004
  2. 84 (3): 787-801. doi: 10.1016/j. suc.2004.03.002 2. Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nature Reviews Endocrinology 2018
  3. 14 (2): 115-125. doi: 10.1038/nrendo.2017.104 3. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10- year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine 1999
  4. 341 (17): 1249-1255. doi: 10.1056/NEJM199910213411701 4. Palmieri S, Roggero L, Cairoli E, Morelli V, Scillitani A et al. Occurrence of malignant neoplasia in patients with primary hyperparathyroidism. European Journal of Internal Medicine 2017
  5. doi: 10.1016/j.ejim.2017.06.001 5. Nilsson IL, Zedenius J, Yin L, Ekbom A. The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocrine-Related Cancer 2007
  6. 14 (1): 135-40. doi: 10.1677/ erc.1.01261 6. Palmér M, Adami HO, Krusemo UB, Ljunghall S. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. American Journal of Epidemiology 1988
  7. 127 (5): 1031-1040. doi: 10.1093/oxfordjournals.aje.a114879 7. Ghosh S, Collier A, Clark D, Elhadd T, Malik I. Primary hyperparathyroidism (Nationwide cohort study): an increased risk of cancer and decreased survival. In: 11th European Congress of Endocrinology. İstanbul, Turkey. 8. Fedorak IJ, Salti G, Fulton N, Schark C, Straus FH 2nd et al. Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: a continuing dilemma. American Surgeon 1994
  8. 60 (6): 427-431 9. Kösem M, Algün E, Kotan C, Harman M, Oztürk M. Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chirurgica Belgica 2004
  9. 104 (5): 568-571. doi: 10.1080/00015458.2004.11679616 10. Kutlutürk K, Otan E, Yağcı MA, Usta S, Aydın C et al. Thyroid pathologies accompanying primary hyperparathyroidism: a high rate of papillary thyroid microcarcinoma. Ulusal Cerrahi Dergisi 2014
  10. 30 (3): 125-128. doi: 10.5152/UCD.2014.2685 11. Palmér M, Adami HO, Krusemo UB, Ljunghall S. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. American Journal of Epidemiology 1988